Upcoming Webinars Archived Webinars Training Vitals Host A Webinar About Get Updates Contact

Earlier Detection Of Foodborne Pathogens Using Nanoparticle Biosensor

XTALKS VITALS NEWS

E. coli

Since even small numbers of pathogenic bacteria can cause illness, it’s important to be able to detect them at low levels.

Share this!

June 21, 2016 | by Sarah Massey, M.Sc.

While food manufacturers perform microbiological testing on their products to ensure they are safe to eat, foodborne pathogens are commonly identified only when individuals become ill. Earlier detection using nanoflower-based biosensors could help prevent cases of foodborne illness, as well as reduce costs associated with food recalls.

Since even small numbers of pathogenic bacteria can cause illness, it’s important to be able to detect them at low levels. Unfortunately, most currently-available biosensors are unable to detect the minute chemical signals released by pathogenic microorganisms.

Researchers at Washington State University think they’ve solved this problem by developing a nanoflower biosensor that can amplify signals from the food pathogen, Escherichia coli O157:H7. Their research was published in the journal, Small.

The biosensor uses a flower-shaped nanoparticle composed of both inorganic and organic compounds. The biosensor is capable of retaining a high level of enzyme activity to detect antigens produced by the diarrhea-causing Escherichia coli O157:H7.



The arrangement of the nanoparticles into a flower shape was no accident; the molecules are arranged like petals on a flower to allow for immobilization of the enzymes used to detect foodborne pathogens at very low levels. By amplifying the chemical signals emitted by the E. coli strain using the nanoparticle biosensor, the researchers found that the bacteria could be detected using a standard pH meter or pH strips.

“We want to take these nanoflowers and create a simple-to-use, handheld device that anyone can use anywhere,” said Yuehe Lin, a professor in WSU's School of Mechanical and Materials Engineering. “It'll be as simple as using a pregnancy test strip or a glucose meter.”

In light of their promising results, the researchers have filed a patent for the technology and are planning to develop biosensors capable of detecting other dangerous food pathogens, including Salmonella.

Tweet: 31 #foodbornepathogens contribute to 48 million cases of illness in US http://ctt.ec/tZcH9+

There are 31 known foodborne pathogens which contribute to the 48 million cases of foodborne illness in the US every year. Just eight of these pathogens are responsible for the majority of the 3,000 foodborne illness-related deaths that occur in the US each year.


Keywords: Food Safety, Nanoparticle, Biosensor


| NEXT ARTICLE | MORE NEWS | BLOGS | VIDEOS | POLLS & QUIZZES | WEBINARS |

Share this with your colleagues!

MORE NEWS
New PARP Inhibitor Drug Approved to Treat Women with Recurrent Ovarian Cancer

March 29, 2017 - The US Food and Drug Administration (FDA) has approved Zejula (niraparib) as a maintenance treatment for women with certain types of recurrent cancers, including epithelial ovarian, fallopian tube, and primary peritoneal cancer.

Featured In: Pharmaceutical News


Nektar’s Opioid Analgesic Meets Endpoints in Phase III Clinical Trial

March 28, 2017 - Nektar Therapeutics has announced that their opioid analgesic has met both its primary and secondary endpoint in a recent Phase III efficacy study.

Featured In: Clinical Trials News


Small Molecule May Disrupt Biofilm Formation on Implantable Medical Devices

March 28, 2017 - Researchers at Trinity College Dublin in Ireland have identified a small molecule capable of preventing bacterial biofilms from growing on medical implants.

Featured In: Medical Device News

LEAVE A COMMENT
 
  
THE XTALKS VITALS LIFE SCIENCE BLOG

Will Pharmaceutical Serialization Solve All of Our Drug Counterfeiting Problems?

REGISTER FOR THESE WEBINARS

Strategies for Deploying Innovative Solutions for Perimeter Security


Natural History vs. Registry Studies in Rare Disease


The FDA Guidance on the Assessment of Abuse Potential of Drug – A Critical Review


Combination Product Regulatory Requirement Complexities and the Impact of the 21st Century Cures Act


Copyright © 2016-2017 Honeycomb Worldwide Inc.